
|Articles|June 1, 1999
Supplements and Featured Publications
- Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women
- Volume 5
- Issue 6 Suppl
Question-and-Answer Session
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
Benefits Foregone: Too Much of the Wrong and Too Little of the Rightover 26 years ago
Breast Cancer Epidemiology: An Overviewover 26 years ago
Overview of Cancer Economicsover 26 years ago
Breast Cancer Stage Cost Analysis in a Managed Care Populationover 26 years ago
Selected AbstractsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
2
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5














































